Customized Treatment Plan: Based on your health profile and weight loss goals, we create a personalized treatment plan
Babadjouni, A., Reddy, M., Zhang, R., Raffi, J., Phong, C., & Mesinkovska, N
While the manufacturers of Mounjaro claim GIP "may complement the effects of GLP-1 receptor agonists," there are limited studies examining the benefits and efficacy of combining the two synthetic incretin hormones
Efpeglenatide, says Hanmi Pharmaceutical, is the first GLP-1 treatment for obesity and metabolic diseases developed independently in South Korea
Compounded semaglutide, with its unique selling points of cost-effectiveness and accessibility, is gaining popularity as a weight loss solution
It works by increasing levels of natural substances called incretins